Retraction
Efficacy of pramipexole combined with levodopa for Parkinson’s disease treatment and their effects on QOL and serum TNF-α levels
Paper Information
Record ID:
50995
Author(s):
Publication Date:
July 31, 2020
Retraction Date:
January 13, 2024
(1.9 year years ago)
Subjects:
Specific Fields:
Biochemistry Neuroscience Medicine - Pharmacology Medicine - Rehabilitation/Therapy
Biochemistry Neuroscience Medicine - Pharmacology Medicine - Rehabilitation/Therapy
Institution:
Department of Neurology, the Third Affiliated Hospital of Soochow University, Changzhou, Jiangsu, ChinaCountry:
🇨🇳 ChinaArticle Type:
Publisher:
SAGE Publications
Open Access:
Yes
PubMed ID:
Retraction PubMed ID:
Retraction Details
Citations (15)
15
Total Citations3
Post-Retraction(20.0%)
12
Pre-Retraction0
Same DayPost-Retraction Citation Analysis
1
Within 30 days
3
Within 1 year
0
After 2+ years
102
Days since retraction (latest)
Tyrosine Hydroxylase Inhibitors and Dopamine Receptor Agonists Combination Therapy for Parkinson’s Disease
Ling Yi, Eng King Tan, Zhidong Zhou
International Journal of Molecular Sciences
Open Access
Published: Apr 2024
7 citations
7 citations
102 days after retraction
A neoteric annotation on the advances in combination therapy for Parkinson’s disease: nanocarrier-based combination approach and future anticipation. Part I: exploring theoretical insights and pharmacological advances
Devika Unnithan, Ali Sartaj, Mohammad Kashif Iqubal et al. (5 authors)
Expert Opinion on Drug Delivery
Published: Mar 2024
50 days after retraction
Adipokines, Vitamin D, and Selected Inflammatory Biomarkers among Parkinson’s Disease Patients with and without Dyskinesia: A Preliminary Examination
Jan Milanowski, Jarosław Nuszkiewicz, Beata Lisewska et al. (5 authors)
Metabolites
Open Access
Published: Feb 2024
2 citations
2 citations
23 days after retraction
Effect of Zishen pingchan granules combined with pramipexole on serum BDNF, IL-1β, IL-6, CRP, TNF-α levels in depressed patients with Parkinson's disease: Results of a randomized, double-blind, controlled study
Houxu Ning, Hao Zhou, Ning Yang et al. (7 authors)
Experimental Gerontology
Open Access
Published: Sep 2023
115 days before retraction
The mechanism of LZ-8-mediated immune response in the mouse model of Parkinson's disease
Hong Cheng, Jingyu Wang, Yahui Zhang et al. (11 authors)
Journal of Neuroimmunology
Published: Jun 2023
1 citation
1 citation
200 days before retraction
Fine-grained selective similarity integration for drug–target interaction prediction
Bin Liu, Jin Wang, Kaiwei Sun et al. (4 authors)
Briefings in Bioinformatics
Open Access
Published: Mar 2023
7 citations
7 citations
318 days before retraction
Peripheral Inflammatory Markers TNF-α and CCL2 Revisited: Association with Parkinson’s Disease Severity
Georgia Xiromerisiou, Chrysoula Marogianni, Ioannis C. Lampropoulos et al. (10 authors)
International Journal of Molecular Sciences
Open Access
Published: Dec 2022
34 citations
34 citations
386 days before retraction
Inflammatory markers and depression in Parkinson’s disease: a systematic review
Luís Guilherme Ramanzini, Luís Fernando Muniz Camargo, Juliana Oliveira Freitas Silveira et al. (4 authors)
Neurological Sciences
Published: Aug 2022
16 citations
16 citations
501 days before retraction
Efficacy of pramipexole on quality of life in patients with Parkinson’s disease: a systematic review and meta-analysis
Tao Li, Shuang Zou, Zijuan Zhang et al. (5 authors)
BMC Neurology
Open Access
Published: Aug 2022
13 citations
13 citations
506 days before retraction
Reorienting of pramipexole as a promising therapy for acute pancreatitis in a rat model by suppressing TLR4\NF-κB p65\NLRP3 inflammasome signaling
Hadeel Fawzy, Asmaa A. Mohammed, Hala M. Fawzy et al. (4 authors)
Canadian Journal of Physiology and Pharmacology
Published: Apr 2022
8 citations
8 citations
641 days before retraction
Efficacy and safety of pramipexole in Parkinson's disease with anxiety or depression: a meta-analysis of randomized clinical trials.
Niu Ji, Pin Meng, Bingchao Xu et al. (4 authors)
PubMed
Published: Jan 2022
13 citations
13 citations
742 days before retraction
Efficacy and safety of combination therapy with pramipexole and levodopa vs levodopa monotherapy in patients with Parkinson disease
Yan Wang, De-Qi Jiang, Cheng-Shu Lu et al. (5 authors)
Medicine
Open Access
Published: Nov 2021
8 citations
8 citations
799 days before retraction
High-quality nursing intervention can improve negative emotions, quality of life and activity of daily living of elderly patients with Parkinson's disease.
Yihui Gui, Youya Zhou
American Journal of Translational Research
Published: May 2021
8 citations
8 citations
973 days before retraction
The role of pramipexole in the treatment of patients with depression and Parkinson's disease: A meta-analysis of randomized controlled trials
De-Qi Jiang, Li-Lin Jiang, Yan Wang et al. (4 authors)
Asian Journal of Psychiatry
Published: May 2021
22 citations
22 citations
978 days before retraction
Comparison of pramipexole and levodopa/benserazide combination therapy versus levodopa/benserazide monotherapy in the treatment of Parkinson’s disease: a systematic review and meta-analysis
De-Qi Jiang, Qing-Min Zang, Li-Lin Jiang et al. (6 authors)
Naunyn-Schmiedeberg s Archives of Pharmacology
Published: May 2021
13 citations
13 citations
981 days before retraction
Quick Stats
Total Citations:
15
Years Since Retraction:
1.9 year
Open Access:
Yes
Last Checked:
Jul 24, 2025